Open AccessBack to the Future: Therapies for Idiopathic Nephrotic Syndrome
Author(s) -
Keisha Gibson,
Dorey A. Glenn,
María Ferris
Publication year - 2015
Publication title -
blood purification
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 57
eISSN - 1421-9735
pISSN - 0253-5068
DOI - 10.1159/000368951
Subject(s) - nephrotic syndrome , medicine , disease , intensive care medicine , kidney disease , immunology , translational research , end stage renal disease , bioinformatics , pathology , biology
Roughly 20-40% of individuals with idiopathic nephrotic syndrome will fail to respond to standard therapies and have a high risk of progression to end stage kidney disease (ESKD). In the last 50 years, no new therapies have been approved specifically for the treatment of these individuals with recalcitrant disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom